Sorrento Therapeutics Inc (SRNE)

$0.00 +0.00 (22.73%)
Market Cap 1.21M
Revenue (ttm) 62.84M
Net Income (ttm) -572.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -911.59%
Debt to Equity Ratio -0.72
Volume 99,400
Avg Vol 105,572
Day's Range N/A - N/A
Shares Out 551.28M
Stochastic %K 16%
Beta 0.97
Analysts Strong Buy
Price Target $9.00

Company Profile

Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease,and pain. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell ther...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 203 4100
Fax: 858 203 4028
Address:
4955 Directors Place, San Diego, United States
idk23
idk23 Jun. 27 at 7:24 AM
$SPY $SRNE $AABB $OCGN just burn it up https://youtu.be/tjtRbO1GCQU?si=gkJgjEk5Stcux7RE
0 · Reply
nelly2k
nelly2k Jun. 27 at 4:17 AM
$SRNE $SCLX who is still holding SRNE .. any longs or shorts still here? or we all retired and living on the beach.
0 · Reply
Tight_grapes
Tight_grapes Jun. 27 at 3:58 AM
$SCLX $SRNE Can a bull explain how this company can remain solvent? This could file for BK any day at this point. Exiting 2025 intact seems close to impossible barring some sort of major asset sale or miraculous rabbit puled out of hat w/ the FDA. They have no trajectory to make money, or even close that I can see, they cannot dilute much more, and the SPAC has not consummated in close to 12 months after annoucement... This looks very much like Sorrento 2.0 and no matter how much Ji "wants" to help, a failing company is a failing company which try as he might, is still failing... Anyone?
1 · Reply
Awaywithshorts
Awaywithshorts Jun. 27 at 2:16 AM
$SRNE Confident Ji won’t let his shares vanish
1 · Reply
maestro_of_the_markets
maestro_of_the_markets Jun. 26 at 8:39 PM
$SRNE why is this shit still trading? 🤦‍♂️
0 · Reply
Tight_grapes
Tight_grapes Jun. 26 at 4:55 PM
$SCLX $SRNE I would bet that the professionals Ji hired at Lantham, M3, and Moelis were not aware at the bankruptcy filing that Scilex was worthless...that the ZTlido patent was junk, Semdexa failed in its Phase 3 design, etc. That truth likely was uncovered during the tortuous BK process and the entire bankruptcy went FUBAR as a result... Lol. But the pumpers attacked the professionals and the courts...not Ji. Ji screwing up is the ESSENCE, the DNA, the foundation of ALL his business dealings. How he can do so, and do so HUGELY, while self-enriching is nothing short of phenomenal. He is the Stephen Curry enrichment by failure. A true legend.
1 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Jun. 26 at 2:35 PM
$SRNE $SCLX
0 · Reply
Awaywithshorts
Awaywithshorts Jun. 26 at 10:52 AM
$SRNE You’ll wake up someday between now and October and be shocked beyond belief. Just my hunch/opinion
4 · Reply
Tight_grapes
Tight_grapes Jun. 25 at 11:18 PM
$SCLX $SRNE Leading up the calamitous Sorrento bankruptcy, it's too bad social media did not have the brains and courage to call out the obvious massive risk. I'll leave this here - if Scilex files for bankruptcy not a single person online can ever say they were surprised or misled. - They lose money every quarter - Their lead product appears to have lost patent protection, and this could impact their 2nd lead candidate SP-103 for neck/low back - Their lead candidate requires a Phase 3 trial that shows no sign of starting in clinicaltrials.gov or spend in any of their 10Q/K's - Their expenses are ridiculous and the executive compensation absurd - The voting structure is horrible, and management incentive are easily perverted for self-enrichment & self-preservation - The investor base is too broke and/or too stupid to hold management accountable legally - They present no plan, communicate no strategy, and treat investors as potential litigants or adversaries Spelling out the obvious
1 · Reply
Tight_grapes
Tight_grapes Jun. 25 at 7:33 PM
$SCLX $SRNE So this is modus operandi of a pumper...trumpet a failure as a success...Sorrento covered up this failure, and it sunk not only Sorrento, but Scilex... Why do you think in BK no one wanted Scilex? Semdexa needed ANOTHER trial AFTER a claimed "pivotal" success...the hope is the "new" FDA waives that but I doubt it. Or they have secretly funded trials, doubt that too... This poster is a VERY bad actor, as are more pumpers on Band of brothers. Call them out, but if you do on Band of Brothers they'll ban you...
1 · Reply
Latest News on SRNE
No data available.
idk23
idk23 Jun. 27 at 7:24 AM
$SPY $SRNE $AABB $OCGN just burn it up https://youtu.be/tjtRbO1GCQU?si=gkJgjEk5Stcux7RE
0 · Reply
nelly2k
nelly2k Jun. 27 at 4:17 AM
$SRNE $SCLX who is still holding SRNE .. any longs or shorts still here? or we all retired and living on the beach.
0 · Reply
Tight_grapes
Tight_grapes Jun. 27 at 3:58 AM
$SCLX $SRNE Can a bull explain how this company can remain solvent? This could file for BK any day at this point. Exiting 2025 intact seems close to impossible barring some sort of major asset sale or miraculous rabbit puled out of hat w/ the FDA. They have no trajectory to make money, or even close that I can see, they cannot dilute much more, and the SPAC has not consummated in close to 12 months after annoucement... This looks very much like Sorrento 2.0 and no matter how much Ji "wants" to help, a failing company is a failing company which try as he might, is still failing... Anyone?
1 · Reply
Awaywithshorts
Awaywithshorts Jun. 27 at 2:16 AM
$SRNE Confident Ji won’t let his shares vanish
1 · Reply
maestro_of_the_markets
maestro_of_the_markets Jun. 26 at 8:39 PM
$SRNE why is this shit still trading? 🤦‍♂️
0 · Reply
Tight_grapes
Tight_grapes Jun. 26 at 4:55 PM
$SCLX $SRNE I would bet that the professionals Ji hired at Lantham, M3, and Moelis were not aware at the bankruptcy filing that Scilex was worthless...that the ZTlido patent was junk, Semdexa failed in its Phase 3 design, etc. That truth likely was uncovered during the tortuous BK process and the entire bankruptcy went FUBAR as a result... Lol. But the pumpers attacked the professionals and the courts...not Ji. Ji screwing up is the ESSENCE, the DNA, the foundation of ALL his business dealings. How he can do so, and do so HUGELY, while self-enriching is nothing short of phenomenal. He is the Stephen Curry enrichment by failure. A true legend.
1 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Jun. 26 at 2:35 PM
$SRNE $SCLX
0 · Reply
Awaywithshorts
Awaywithshorts Jun. 26 at 10:52 AM
$SRNE You’ll wake up someday between now and October and be shocked beyond belief. Just my hunch/opinion
4 · Reply
Tight_grapes
Tight_grapes Jun. 25 at 11:18 PM
$SCLX $SRNE Leading up the calamitous Sorrento bankruptcy, it's too bad social media did not have the brains and courage to call out the obvious massive risk. I'll leave this here - if Scilex files for bankruptcy not a single person online can ever say they were surprised or misled. - They lose money every quarter - Their lead product appears to have lost patent protection, and this could impact their 2nd lead candidate SP-103 for neck/low back - Their lead candidate requires a Phase 3 trial that shows no sign of starting in clinicaltrials.gov or spend in any of their 10Q/K's - Their expenses are ridiculous and the executive compensation absurd - The voting structure is horrible, and management incentive are easily perverted for self-enrichment & self-preservation - The investor base is too broke and/or too stupid to hold management accountable legally - They present no plan, communicate no strategy, and treat investors as potential litigants or adversaries Spelling out the obvious
1 · Reply
Tight_grapes
Tight_grapes Jun. 25 at 7:33 PM
$SCLX $SRNE So this is modus operandi of a pumper...trumpet a failure as a success...Sorrento covered up this failure, and it sunk not only Sorrento, but Scilex... Why do you think in BK no one wanted Scilex? Semdexa needed ANOTHER trial AFTER a claimed "pivotal" success...the hope is the "new" FDA waives that but I doubt it. Or they have secretly funded trials, doubt that too... This poster is a VERY bad actor, as are more pumpers on Band of brothers. Call them out, but if you do on Band of Brothers they'll ban you...
1 · Reply
BioCEOsSukk
BioCEOsSukk Jun. 25 at 6:43 PM
$SRNE over 112k average ten day volume - and two big albeit short-lasting spikes over the last few days. Something's coming IMO...
0 · Reply
Tight_grapes
Tight_grapes Jun. 25 at 6:17 PM
$SCLX $SRNE Has anyone noticed there is zero financial due diligence going on with pumper. Just social media posts, political posts, conspiracies, etc. Nothing product related. Nothing financial related. Nothing management related. 98% don't know any better and should never have invested in a single stock outside an ETF. 2% know better and are serious con artists...
2 · Reply
CharlyBue
CharlyBue Jun. 25 at 2:55 PM
$SRNE Bingo 👊 https://cases.stretto.com/public/x228/12086/PLEADINGS/1208606162580000000164.pdf Page 7! That all Avoidable Transfers avoided pursuant to 11 U.S.C. § 547 be recovered by the Trustee from Defendant pursuant to 11 U.S.C. § 550;
1 · Reply
JustNumberstome
JustNumberstome Jun. 25 at 1:01 PM
$SCLX $SRNE KDS2010 12/10/24 Scilex Bio Term sheet with NeuroBiogen, now these below https://www.clinicaltrials.gov/study/NCT07027072?term=Neurobiogen&rank=2 https://www.clinicaltrials.gov/study/NCT07009171?term=Neurobiogen&rank=1 "PALO ALTO, Calif. and SEOUL, South Korea, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Scilex Bio, a controlling interest of joint venture by Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”) today announced the signing of a binding term sheet with NeuroBiogen (“NB”) to grant Scilex Bio an exclusive worldwide license to the franchise KDS2010 drug candidate to develop and commercialize in metabolic diseases (including obesity and type 2 diabetes) and neurodegenerative diseases, including Alzheimer’s, Parkinson’s and other CNS diseases. The lead program in the proposed joint venture is an oral tablet product candidate that is currently in Phase 2 trials in obesity and Alzheimer’s disease indications. The term sheet provides that NeuroBiogen will grant Scilex Bio the worldwide license rights along with the rights to sublicense for all KDS2010 indications."
2 · Reply
Awaywithshorts
Awaywithshorts Jun. 25 at 11:15 AM
$SRNE Shorts posting old news. Shorts very nervous. They need to return more shares than are available which means they could Lose their shorts. No pun intended. lol
0 · Reply
CharlyBue
CharlyBue Jun. 25 at 8:56 AM
$SCLX $SRNE Don't be surprised if there is no dividend, read 🤷‍♂️ https://finance.yahoo.com/news/scilex-holding-company-announces-deferral-205000613.html
0 · Reply
JustAGoodOleBoy22
JustAGoodOleBoy22 Jun. 24 at 6:59 PM
$SRNE $SCLX Stockholm syndrome? You diagnosing patients like a doctor now? Do you have 🇳🇪 Niger Syndrome?
0 · Reply
Tight_grapes
Tight_grapes Jun. 24 at 5:17 PM
$SCLX $SRNE Has it crossed any pumpers mind that management has pulled the dividend ruse to trick retail to pump in liquidity? Then rinse and repeat? This management is an awful 'regime' and their supporters are like the crazed citizens in the streets marching for their dictator. Lol...Henry Ji should have been a Middle East dictator...and his pumpers missed their life calling as a Imams, Mullahs, and mobs chanting...
1 · Reply
Tight_grapes
Tight_grapes Jun. 24 at 4:30 AM
$SCLX $SRNE In the 6 years I have followed this company or Ji's mutant public monstrosities, he has delayed dozens and dozens of times. Some with poor explanations. Most with none. They have always meant one thing - DISASTER for investors, employees, creditors, vendors, partners...lol. I would say being BULLISH about the continued delay with Semnur is, to put it mildly, setting yourself up for disappointment. lol...
0 · Reply
Awaywithshorts
Awaywithshorts Jun. 24 at 2:43 AM
$SRNE Rise of the Phoenix- after we exit C11 - somebody cut a deal with the creditors already? Yes — you're exactly on point. The Net Operating Losses (NOLs) combined with the shell status post-bankruptcy and potential reverse merger via Vivasor do form the core of the speculative bull thesis around Sorrento (SRNEQ). Here's how that adds up: F 1. NOLs - Net Operating Loss Carryforwards Sorrento reportedly has hundreds of millions in federal and state NOLS. If preserved through Chapter 11 (not canceled or impaired), they could: Shield future profits of a merged/ acquiring entity. Provide significant tax advantages making Sorrento an attractive reverse merger target. 
1 · Reply
Tight_grapes
Tight_grapes Jun. 23 at 9:51 PM
$SCLX $SRNE How about we mix this up a little... How can Scilex *NOT* go bankrupt by the end of the year? Anyone have a golden path, however unlikely? I am having a hard time mapping any scenario the company remains solvent.
1 · Reply
Tight_grapes
Tight_grapes Jun. 23 at 9:05 PM
$SCLX $SRNE Would a well managed company move dividend dates? How about quorum issues? How about conference calls or investor updates? Welcome to the worst publicly run company in public markets, its merry band of sociopathic cult leaders pumpers and the idiot flock of followers!
2 · Reply